Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Stem Cell Therapeutics Corp.

Stem Cell Therapeutics is a publicly listed Canadian biotechnology company headquartered in Calgary, Alberta. The company is focused on the development and commercialization of Therapeutics that control adult stem cells in the body. We leverage the experience and expertise of our efficient team with numerous contract relationships.


Contact Details:
Suite 1000, 1520 4th St SW
Calgary
Alberta
T2R 1H5
Canada
Tel:403.245.5495
Fax:403.245.5411
Email:
WWW:

www.stemcellthera.com/




Loading...

Recent Publications by Stem Cell Therapeutics Corp.:

Open labeled, uncontrolled pharmacokinetic study of a single intramuscular hCG dose in healthy male volunteers.
The current study was designed to compare blood and cerebrospinal fluid...
3rd October, 2009
Stem Cell Therapeutics Corp., Calgary, Alberta, Canada. Int J Clin Pharmacol Ther. 2009 Aug;47(8):516-24.

Press Releases on Stem Cell Therapeutics Corp.:

BioPortfolio Logo
Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 13th May, 2009 Transition Therapeutics Inc.
TORONTO, May 13 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company
Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 11th February, 2009 Transition Therapeutics Inc.
TORONTO, Feb. 11 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company
Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results 10th November, 2008 Transition Therapeutics Inc.
TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company

BioNews Results for Stem Cell Therapeutics Corp.:

Stem Cell Therapeutics Corp. Announces Positive Review By Data Safety And Monitoring Board For The Phase IIb S
Medical News Today:  Nov 22 2009 11:40AM Matching: stem cell therapeutics corp
Medical News: Stem Cell Therapeutics Corp. Announces Positive Review By Data Safety And Monitoring Board For The Phase IIb Stroke Trial
BioFind:  Nov 22 2009 11:44AM Matching: stem cell therapeutics corp
Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb Stroke Trial
Individual.com:  Nov 21 2009 6:26AM Matching: stem cell therapeutics corp
Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb Stroke Trial
Individual.com:  Nov 21 2009 6:26AM Matching: stem cell therapeutics corp
Stem Cell Therapeutics (SSS.V) Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb
BioSpace:  Nov 21 2009 12:39AM Matching: stem cell therapeutics corp
Promote your company here: BioNewsCast - Press Release Distribution

View more Stem Cell Therapeutics Corp. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 312 times since April 2007, the link to the organisation's website has been followed 71 times

Search for more companies in Calgary

Search for more companies in Alberta



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Stem Cell Therapeutics Corp.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.